Tempest Therapeutics Stock In The News

TPST Stock  USD 1.26  0.04  3.08%   
Our overall analysis of Tempest Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Tempest Therapeutics. The specific impact of Tempest Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Tempest Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Tempest Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Tempest Therapeutics Backtesting and Tempest Therapeutics Hype Analysis.
For more information on how to buy Tempest Stock please use our How to Invest in Tempest Therapeutics guide.

Tempest Therapeutics Today Top News and Investor Outlook

Yahoo News
11 Hot Healthcare Stocks To Buy Now
https://finance.yahoo.com/news/11-hot-healthcare-stocks-buy-003552229.html
 Bullish
Macroaxis News: globenewswire.com
Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference
https://www.globenewswire.com/news-release/2023/11/20/2783167/0/en/Tempest-to-Present-at-the-35th-Annual-Piper-Sandler-Healthcare-Conference.html
 Neutral
Macroaxis News: globenewswire.com
Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update
https://www.globenewswire.com/news-release/2023/11/08/2776817/0/en/Tempest-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
 Bullish
Yahoo News
12 Best Performing Biotech Stocks in 2023
https://finance.yahoo.com/news/12-best-performing-biotech-stocks-172229011.html
 Bullish
Yahoo News
Market Today: Pfizer's Acquisition of Seagen Under Review, NextEra Energy Rebounds, and Tempest ...
https://finance.yahoo.com/news/market-today-pfizers-acquisition-seagen-213142492.html
 Neutral
Yahoo News
Stock Market Today: Dow ends higher as focus shifts to consumer inflation data
https://finance.yahoo.com/news/stock-market-today-dow-ends-165338334.html
 Bullish
Yahoo News
Google AI-Powered Chatbot's Ethical Conc...
https://finance.yahoo.com/news/google-ai-powered-chatbots-ethical-153635257.html
 Bullish
Macroaxis News: globenewswire.com
Tempest Adopts Limited Duration Stockholder Rights Plan
https://www.globenewswire.com/news-release/2023/10/11/2758322/0/en/Tempest-Adopts-Limited-Duration-Stockholder-Rights-Plan.html
 Bullish
Macroaxis News: globenewswire.com
Tempest Releases New Data Demonstrating Superiority of TPST-1120 Arm Across Multiple Study Endpoints in Randomized First-Line HCC Study
https://www.globenewswire.com/news-release/2023/10/11/2758300/0/en/Tempest-Releases-New-Data-Demonstrating-Superiority-of-TPST-1120-Arm-Across-Multiple-Study-Endpoints-in-Randomized-First-Line-HCC-Study.html
 Neutral
Macroaxis News: globenewswire.com
Tempest to Report New and Updated Data from Global Randomized Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
https://www.globenewswire.com/news-release/2023/10/10/2757908/0/en/Tempest-to-Report-New-and-Updated-Data-from-Global-Randomized-Combination-Study-of-TPST-1120-in-First-Line-Hepatocellular-Carcinoma.html
 Bullish

Tempest Therapeutics Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Tempest and other traded companies coverage with news coverage. We help investors stay connected with Tempest headlines for the 25th of September to make an informed investment decision based on correlating the impacts of news items on Tempest Stock performance. Please note that trading solely based on the Tempest Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Tempest Therapeutics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Tempest Therapeutics investors visualize upcoming and past events in order to time the market based on Tempest Therapeutics noise-free hype analysis.
Tempest Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Tempest earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Tempest Therapeutics that are available to investors today. That information is available publicly through Tempest media outlets and privately through word of mouth or via Tempest internal channels. However, regardless of the origin, that massive amount of Tempest data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tempest Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tempest Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tempest Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tempest Therapeutics alpha.

Tempest Largest EPS Surprises

Earnings surprises can significantly impact Tempest Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-11-08
2023-09-30-0.57-0.480.0915 
2023-05-10
2023-03-31-0.64-0.550.0914 
2023-03-22
2022-12-31-0.76-0.630.1317 
2022-08-15
2022-06-30-0.92-0.790.1314 
2022-11-08
2022-09-30-0.8-0.660.1417 
2021-11-10
2021-09-30-1.05-1.21-0.1615 
View All Earnings Estimates

Tempest Therapeutics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Tempest Therapeutics Stock. The global stock market is bullish. About 68% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
18th of September 2024
Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice Pr...
at finance.yahoo.com 
Yahoo News
23rd of August 2024
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635
at finance.yahoo.com 
seekingalpha News
15th of August 2024
Tempest stock jumps on positive FDA feedback
at seekingalpha.com 
sbwire news
9th of August 2024
TPST Stock Earnings Tempest Therapeutics Misses EPS for Q2 2024
at investorplace.com 
Macroaxis News
25th of July 2024
Insider Trading
at MacroaxisInsider 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tempest Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tempest Therapeutics' short interest history, or implied volatility extrapolated from Tempest Therapeutics options trading.

Additional Tools for Tempest Stock Analysis

When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.